Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Massachusetts Institute of Technology et al v. Shire Pharmaceuticals, Inc.
Case Number:
1:13-cv-10020
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 13, 2016
Fed. Circ. Backs MIT In Cell-Growing Mesh Patent Case
The Federal Circuit on Thursday affirmed a win for the Massachusetts Institute of Technology in its patent infringement suit against Shire Pharmaceuticals Inc. over the drugmaker's Dermagraft treatment for diabetic foot ulcers, saying the district court's claim constructions were correct and that a key term was not indefinite.
-
January 04, 2013
MIT Sues Shire Over Cell-Growing Mesh IP
The Massachusetts Institute of Technology on Friday hit Shire PLC with a patent infringement suit in Massachusetts federal court, alleging that the drugmaker's Dermagraft treatment for diabetic foot ulcers uses a protected method of growing cells to replace damaged skin.